CANDELORO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 714
AS - Asia 390
EU - Europa 388
SA - Sud America 49
Continente sconosciuto - Info sul continente non disponibili 35
AF - Africa 11
OC - Oceania 1
Totale 1.588
Nazione #
US - Stati Uniti d'America 679
SG - Singapore 193
IT - Italia 86
CN - Cina 81
DE - Germania 52
IE - Irlanda 51
HK - Hong Kong 46
RU - Federazione Russa 45
BR - Brasile 32
UA - Ucraina 27
SE - Svezia 26
FI - Finlandia 23
FR - Francia 22
VN - Vietnam 20
GB - Regno Unito 17
CA - Canada 14
IN - India 14
ES - Italia 12
MX - Messico 10
AR - Argentina 8
BE - Belgio 8
PL - Polonia 6
BD - Bangladesh 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
KR - Corea 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
IQ - Iraq 3
TR - Turchia 3
TT - Trinidad e Tobago 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
GT - Guatemala 2
JM - Giamaica 2
JP - Giappone 2
KE - Kenya 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
VE - Venezuela 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CW - ???statistics.table.value.countryCode.CW??? 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
NL - Olanda 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
ZW - Zimbabwe 1
Totale 1.554
Città #
Singapore 153
Chandler 88
San Jose 73
Ashburn 53
Dublin 52
Perugia 47
Hong Kong 46
Ann Arbor 41
Munich 32
Santa Clara 29
San Mateo 28
Beijing 25
Council Bluffs 19
Wilmington 18
Altamura 16
Boardman 16
Jacksonville 15
Princeton 15
Medford 14
Moscow 14
Lauterbourg 12
Lawrence 12
Helsinki 10
Ho Chi Minh City 10
Valencia 10
Los Angeles 9
Brussels 8
Frankfurt am Main 7
Juárez 6
New York 6
Redmond 6
Woodbridge 6
Atlanta 5
North Bergen 5
The Dalles 5
Brooklyn 4
Des Moines 4
Falls Church 4
Hanoi 4
Saint Petersburg 4
Seoul 4
Andover 3
Baku 3
Buenos Aires 3
Corridonia 3
Dallas 3
Houston 3
Lucknow 3
Montreal 3
Olomouc 3
Orem 3
Toronto 3
Turku 3
Amelia 2
Belo Horizonte 2
Bogotá 2
Bucu 2
Chicago 2
Denver 2
Detroit 2
Durban 2
Heidelberg 2
Hyderabad 2
Las Vegas 2
North Charleston 2
Osasco 2
Palermo 2
Redwood City 2
Rome 2
Rouen 2
San Francisco 2
San José 2
San Paolo di Civitate 2
Stockholm 2
Tashkent 2
Tokyo 2
Warsaw 2
Abuja 1
Agrolândia 1
Ahmedabad 1
Ankara 1
Araguaína 1
Arar 1
Arlington 1
Ashtabula 1
Astana 1
Asunción 1
Athens 1
Baghdad 1
Baoding 1
Barataria 1
Barinas 1
Barueri 1
Birmingham 1
Bismarck 1
Bloomfield 1
Bloomington 1
Brampton 1
Brasilândia de Minas 1
Brno 1
Totale 1.042
Nome #
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 173
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 168
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 143
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 129
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 119
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 106
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 105
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 103
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 103
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 100
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 96
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 89
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 81
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 73
Totale 1.588
Categoria #
all - tutte 7.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022102 0 0 0 0 7 4 2 35 4 9 27 14
2022/2023234 15 45 7 27 20 28 0 8 74 0 7 3
2023/202494 6 8 5 1 2 0 18 0 4 3 34 13
2024/2025202 1 15 5 35 25 6 1 19 32 13 33 17
2025/2026501 37 20 32 26 88 26 100 28 86 36 18 4
2026/2027206 51 13 27 102 13 0 0 0 0 0 0 0
Totale 1.588